Bohui Innovation Biotechnology Secures Approval for Virus Detection Kit
I'm PortAI, I can summarize articles.
Beijing Bohui Innovation Biotechnology received regulatory approval from China's medical products administrator for a third class in vitro diagnostic reagent. The nucleic acid detection kit targets rotavirus, norovirus, enteric adenovirus, astrovirus and sapovirus in stool samples, according to a May 31 filing with the Shenzhen bourse. The certificate is valid until May 28, 2030.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Trading View The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments